Literature DB >> 27477687

Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties.

Niek G J Leus1, Birgit Honrath2, Nikolaos Eleftheriadis1, Hessel Poelman1, Constantinos G Neochoritis3, Amalia Dolga4, Alexander Dömling3, Frank J Dekker1.   

Abstract

The enzyme 15-lipoxygenase-1 (15-LOX-1) plays a dual role in diseases with an inflammatory component. On one hand 15-LOX-1 plays a role in pro-inflammatory gene expression and on the other hand it has been shown to be involved in central nervous system (CNS) disorders by its ability to mediate oxidative stress and damage of mitochondrial membranes under hypoxic conditions. In order to further explore applications in the CNS, novel 15-LOX-1 inhibitors with favorable physicochemical properties need to be developed. Here, we present Substitution Oriented Screening (SOS) in combination with Multi Component Chemistry (MCR) as an effective strategy to identify a diversely substituted small heterocyclic inhibitors for 15-LOX-1, denoted ThioLox, with physicochemical properties superior to previously identified inhibitors. Ex vivo biological evaluation in precision-cut lung slices (PCLS) showed inhibition of pro-inflammatory gene expression and in vitro studies on neuronal HT-22 cells showed a strong protection against glutamate toxicity for this 15-LOX-1 inhibitor. This provides a novel approach to identify novel small with favorable physicochemical properties for exploring 15-LOX-1 as a drug target in inflammatory diseases and neurodegeneration.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  15-Lipoxygenase; Inflammation; Multi component chemistry; Neurodegeneration; Substitution Oriented Screening; Thiophene-based inhibitor

Mesh:

Substances:

Year:  2016        PMID: 27477687      PMCID: PMC5010146          DOI: 10.1016/j.ejmech.2016.07.010

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  56 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Inflammation and therapeutic vaccination in CNS diseases.

Authors:  Howard L Weiner; Dennis J Selkoe
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 3.  Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease.

Authors:  Jesper Z Haeggström; Colin D Funk
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

4.  Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.

Authors:  Ahmed S Ibrahim; Amany M Tawfik; Khaled A Hussein; Sally Elshafey; Shanu Markand; Nasser Rizk; Elia J Duh; Sylvia B Smith; Mohamed Al-Shabrawey
Journal:  Biochim Biophys Acta       Date:  2015-01-03

5.  Continuous-flow synthesis of monoarylated acetaldehydes using aryldiazonium salts.

Authors:  Natalia Chernyak; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2012-07-19       Impact factor: 15.419

6.  12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress.

Authors:  Stefanie Pallast; Ken Arai; Xiaoying Wang; Eng H Lo; Klaus van Leyen
Journal:  J Neurochem       Date:  2009-09-08       Impact factor: 5.372

7.  15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.

Authors:  Fei Mao; Min Xu; Xiangsheng Zuo; Jiang Yu; Weiguo Xu; Micheline J Moussalli; Elias Elias; Haiyan S Li; Stephanie S Watowich; Imad Shureiqi
Journal:  FASEB J       Date:  2015-02-24       Impact factor: 5.191

8.  Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.

Authors:  Nikolaos Eleftheriadis; Stephanie Thee; Johan te Biesebeek; Petra van der Wouden; Bert-Jan Baas; Frank J Dekker
Journal:  Eur J Med Chem       Date:  2015-03-05       Impact factor: 6.514

9.  Novel lipoxygenase inhibitors as neuroprotective reagents.

Authors:  Klaus van Leyen; Ken Arai; Guang Jin; Victor Kenyon; Bettina Gerstner; Paul A Rosenberg; Theodore R Holman; Eng H Lo
Journal:  J Neurosci Res       Date:  2008-03       Impact factor: 4.164

10.  Involvement of 15-lipoxygenase in the inflammatory arthritis.

Authors:  Ming-Yueh Wu; Tzu-Hung Lin; Yung-Cheng Chiu; Houng-Chi Liou; Rong-Sen Yang; Wen-Mei Fu
Journal:  J Cell Biochem       Date:  2012-07       Impact factor: 4.429

View more
  6 in total

Review 1.  The Potential of Ferroptosis-Targeting Therapies for Alzheimer's Disease: From Mechanism to Transcriptomic Analysis.

Authors:  Nad'a Majerníková; Wilfred F A den Dunnen; Amalia M Dolga
Journal:  Front Aging Neurosci       Date:  2021-12-20       Impact factor: 5.750

2.  Spectroscopic Studies of Dual Fluorescence in 2-(4-Fluorophenylamino)-5-(2,4-dihydroxybenzeno)-1,3,4-thiadiazole: Effect of Molecular Aggregation in a Micellar System.

Authors:  Grzegorz Czernel; Arkadiusz Matwijczuk; Dariusz Karcz; Andrzej Górecki; Agnieszka Niemczynowicz; Aleksandra Szcześ; Grzegorz Gładyszewski; Alicja Matwijczuk; Bożena Gładyszewska; Andrzej Niewiadomy
Journal:  Molecules       Date:  2018-11-02       Impact factor: 4.411

3.  Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity.

Authors:  Hao Guo; Iris C Verhoek; Gerian G H Prins; Ramon van der Vlag; Petra E van der Wouden; Ronald van Merkerk; Wim J Quax; Peter Olinga; Anna K H Hirsch; Frank J Dekker
Journal:  J Med Chem       Date:  2019-04-19       Impact factor: 7.446

4.  Screening drug target combinations in disease-related molecular networks.

Authors:  Min Luo; Jianfeng Jiao; Ruiqi Wang
Journal:  BMC Bioinformatics       Date:  2019-05-01       Impact factor: 3.169

Review 5.  Fatty Acid Allosteric Regulation of C-H Activation in Plant and Animal Lipoxygenases.

Authors:  Adam R Offenbacher; Theodore R Holman
Journal:  Molecules       Date:  2020-07-24       Impact factor: 4.411

6.  Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione Derivative Inhibits d-Dopachrome Tautomerase Activity and Suppresses the Proliferation of Non-Small Cell Lung Cancer Cells.

Authors:  Zhangping Xiao; Angelina Osipyan; Shanshan Song; Deng Chen; Reinder A Schut; Ronald van Merkerk; Petra E van der Wouden; Robbert H Cool; Wim J Quax; Barbro N Melgert; Gerrit J Poelarends; Frank J Dekker
Journal:  J Med Chem       Date:  2022-01-18       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.